Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
- 18 November 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Advances in Therapy
- Vol. 25 (11), 1105-1140
- https://doi.org/10.1007/s12325-008-0118-7
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varicesJournal of Hepatology, 2008
- Liver cirrhosisThe Lancet, 2008
- Ischaemic complications of Glypressin in liver disease: a case seriesBritish Journal of Clinical Pharmacology, 2007
- Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic supportJournal of Hepatology, 2007
- Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascitesJournal of Hepatology, 2007
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- Time profile of the haemodynamic effects of terlipressin in portal hypertensionJournal of Hepatology, 1997
- Cloning, Functional Expression and Tissue Distribution of Human cDNA for the Vascular-Type Vasopressin ReceptorBiochemical and Biophysical Research Communications, 1994
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988